Using patient-derived organoids to predict locally advanced or metastatic lung cancer tumor response: A real-world study

Predicting the clinical response to chemotherapeutic or targeted treatment in patients with locally advanced or metastatic lung cancer requires an accurate and affordable tool. Tumor organoids are a potential approach in precision medicine for predicting the clinical response to treatment. However,...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Han-Min, Zhang, Chan-Yuan, Peng, Kai-Cheng, Chen, Ze-Xin, Su, Jun-Wei, Li, Yu-Fa, Li, Wen-Feng, Gao, Qing-Yun, Zhang, Shi-Ling, Chen, Yu-Qing, Zhou, Qing, Xu, Cong, Xu, Chong-Rui, Wang, Zhen, Su, Jian, Yan, Hong-Hong, Zhang, Xu-Chao, Chen, Hua-Jun, Wu, Yi-Long, Yang, Jin-Ji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9975107/
https://www.ncbi.nlm.nih.gov/pubmed/36657446
http://dx.doi.org/10.1016/j.xcrm.2022.100911

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9975107/
https://www.ncbi.nlm.nih.gov/pubmed/36657446
http://dx.doi.org/10.1016/j.xcrm.2022.100911

Ejemplares similares